NCT01714401View on ClinicalTrials.gov

Nebulized Bronchodilators and Cardiac Repolarization

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 30, 2013

Study Completion Date

December 31, 2013

Conditions
Influence of Nebulized Bronchodilatators on SelectedElectrophysiological Parameters
Interventions
DRUG

Salbutamol 2,5 mg

20 min nebulization of 2.5 mg of salbutamol

DRUG

Salbutamol 5mg

20 min nebulization of 5 mg of salbutamol

Trial Locations (2)

80-214

Medical University of Gdansk - Departament of Anesthesiolog and Intensive cCre, Gdansk

Medical University of Gdańsk - Departament of Anesthesiology and Intensive Care, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT01714401 - Nebulized Bronchodilators and Cardiac Repolarization | Biotech Hunter | Biotech Hunter